Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

NCT: NCT04741009 · COMPLETED

NCT IDNCT04741009
StatusCOMPLETED
Start Date2021-12-16
Completion2025-06-16
SponsorCochlear (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

Frequently Asked Questions

What is Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing?

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing is a clinical trial registered under NCT04741009. Current status: COMPLETED.

What is the status of NCT04741009?

The current status of NCT04741009 (Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing) is: COMPLETED.

When did Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing start?

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing started on 2021-12-16.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.